ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Central Nervous System Neoplasms is on this study

  • ClinicalTrials.gov files the study under Central Nervous System Neoplasms.
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Central Nervous System Neoplasms.
  • Rule based: a wider term: a narrower one is filed too.
16 links0 made here, not in the record17 judgments1 judge (the rules as one: Rule based)2 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT04541082Phase I Study of OralONC206 in Recurrent andRare Primary CentralNervous System NeoplasmsJazz PharmaceuticalsPhase 1 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Nov 9 · ClinicalTrials.gov record · Version of 2026-11-09Version of 2026-11-09CONDITIONSCentral Nervous System Neop…The registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedAs of now · Rule based · Main conditionMain conditionGlioblastomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termGliosarcomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termOligodendrogliomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termAstrocytomaThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedNeoplasms, NeuroepithelialThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedEpendymomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termMedulloblastomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termTypical Teratoid Rhabdoid T…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termNeuroectodermal Tumors, Pri…The registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedNeuroectodermal TumorsThe registry's MeSH filing›Nov 14 · Rule based · Wider: a narrower term is filedWider: a narrower term is filedMeningiomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termChoroid Plexus NeoplasmsThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termPinealomaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termGliomaThe registry's MeSH filing›Nov 14 · Rule based · General: a category, not a diseaseGeneral: a category, not a diseaseDRUGSONC206Intervention entry›As of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
2 versions of the record seen on ClinicalTrials.gov, Oct 23–Nov 9 · changes seen, not judgments
Nov 14Central Nervous System NeoplasmsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14GlioblastomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14GliosarcomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14OligodendrogliomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14AstrocytomaRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Neoplasms, NeuroepithelialRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14EpendymomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14MedulloblastomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Typical Teratoid Rhabdoid TumorRule based · condition-kind ruleFinest filed termCurrent
Nov 14Neuroectodermal Tumors, PrimitiveRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14Neuroectodermal TumorsRule based · condition-kind ruleWider: a narrower term is filedCurrent
Nov 14MeningiomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Choroid Plexus NeoplasmsRule based · condition-kind ruleFinest filed termCurrent
Nov 14PinealomaRule based · condition-kind ruleFinest filed termCurrent
Nov 14GliomaRule based · condition-kind ruleGeneral: a category, not a diseaseCurrent
As of nowCentral Nervous System NeoplasmsRule based · main-condition ruleMain conditionCurrent
As of nowONC206Rule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.